Specificity | Clone | Host Species | Reactive Species | Format | Size | Reviews | Supplier | |
---|---|---|---|---|---|---|---|---|
S Protein | OTI4G5 | Mouse | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
S Protein | OTIR4G5 | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
S Protein | OTIR5E2 | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
S Protein | OTIR5F11 | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
S Protein | OTIR5G6 | Rabbit | SARS-CoV-2 | unconjugated | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
Influenza H5N1 (A/chicken/VietNam/NCVD-016/2008) Hemagglutinin / HA1 | polyclonal | Rabbit | n/a | antigen affinity purified | 100µL | n/a |
SINO BIOLOGICAL, INC. |
More Info |
Mouse H-2Kb | AF6-88.5 | Mouse (BALB/c) | mouse | PerCP-Cyanine5.5 conjugate | 25 µg | n/a |
BIOLEGEND |
More Info |
Mouse H-2Kb | AF6-88.5 | Mouse (BALB/c) | mouse | PerCP-Cyanine5.5 conjugate | 100 µg | n/a |
BIOLEGEND |
More Info |
Nav1.1 | polyclonal | n/a | human, mouse, rat | immunogen affinity purified | 0.03 mL, 0.1 mL, 0.2 mL | n/a |
MYBIOSOURCE INC. |
More Info |
Human TCR Vα7.2 | 3C10 | Mouse | human | PerCP-Cyanine5.5 conjugate | 25 tests | n/a |
BIOLEGEND |
More Info |
Human TCR Vα7.2 | 3C10 | Mouse | human | PerCP-Cyanine5.5 conjugate | 100 tests | n/a |
BIOLEGEND |
More Info |
Mouse PD-1H (VISTA) | MH5A | Armenian Hamster | mouse | PerCP-Cyanine5.5 conjugate | 100 µg | n/a |
BIOLEGEND |
More Info |
Na+ CP type I alpha | polyclonal | Rabbit | human, mouse, rat | peptide affinity purified | 0.1 mL, 0.2 mL | n/a |
MYBIOSOURCE INC. |
More Info |
SARS-CoV/SARS-CoV-2 Spike Glycoprotein RBD | D003 | Chimeric | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 Omicron (BA.1.1), SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron (BA.2.12.1), SARS-CoV-2 Omicron (BA.2.75.2), SARS-CoV-2 (BA.2.3.20), SARS-CoV-2 (BA.2.75), SARS-CoV-2 Omicron (BA.4), SARS-CoV-2 Omicron (BA.4.6 / BF.7), SARS-CoV-2 Omicron (BA.5), SARS-CoV-2 Omicron (BQ.1.1), SARS-CoV-2 Omicron (XBB) | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
SARS-CoV/SARS-CoV-2 Spike Glycoprotein RBD | D003 | Chimeric | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 Omicron (BA.1.1), SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron (BA.2.12.1), SARS-CoV-2 Omicron (BA.2.75.2), SARS-CoV-2 (BA.2.3.20), SARS-CoV-2 (BA.2.75), SARS-CoV-2 Omicron (BA.4), SARS-CoV-2 Omicron (BA.4.6 / BF.7), SARS-CoV-2 Omicron (BA.5), SARS-CoV-2 Omicron (BQ.1.1), SARS-CoV-2 Omicron (XBB) | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
SARS-CoV/SARS-CoV-2 Spike Glycoprotein RBD | D004 | Chimeric | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.1.1), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron (BA.2.12.1), SARS-CoV-2 (BA.2.3.20), SARS-CoV-2 (BA.2.75), SARS-CoV-2 Omicron (BA.2.75.2), SARS-CoV-2 Omicron (BA.4), SARS-CoV-2 Omicron (BA.4.6 / BF.7), SARS-CoV-2 Omicron (BA.5), SARS-CoV-2 Omicron (BQ.1.1), SARS-CoV-2 Omicron (XBB) | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
SARS-CoV/SARS-CoV-2 Spike Glycoprotein RBD | D004 | Chimeric | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.1.1), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron (BA.2.12.1), SARS-CoV-2 (BA.2.3.20), SARS-CoV-2 (BA.2.75), SARS-CoV-2 Omicron (BA.2.75.2), SARS-CoV-2 Omicron (BA.4), SARS-CoV-2 Omicron (BA.4.6 / BF.7), SARS-CoV-2 Omicron (BA.5), SARS-CoV-2 Omicron (BQ.1.1), SARS-CoV-2 Omicron (XBB) | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
SARS-CoV/SARS-CoV-2 Spike Glycoprotein RBD | D005 | Chimeric | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 Omicron (BA.1.1), SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron (BA.2.12.1), SARS-CoV-2 Omicron (BA.2.75.2), SARS-CoV-2 (BA.2.3.20), SARS-CoV-2 (BA.2.75), SARS-CoV-2 Omicron (BA.4), SARS-CoV-2 Omicron (BA.4.6 / BF.7), SARS-CoV-2 Omicron (BA.5), SARS-CoV-2 Omicron (BQ.1.1), SARS-CoV-2 Omicron (XBB) | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
SARS-CoV/SARS-CoV-2 Spike Glycoprotein RBD | D005 | Chimeric | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 Omicron (BA.1.1), SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron (BA.2.12.1), SARS-CoV-2 Omicron (BA.2.75.2), SARS-CoV-2 (BA.2.3.20), SARS-CoV-2 (BA.2.75), SARS-CoV-2 Omicron (BA.4), SARS-CoV-2 Omicron (BA.4.6 / BF.7), SARS-CoV-2 Omicron (BA.5), SARS-CoV-2 Omicron (BQ.1.1), SARS-CoV-2 Omicron (XBB) | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
SARS-CoV/SARS-CoV-2 Spike Glycoprotein RBD | D006 | Chimeric | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 Omicron (BA.1.1), SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron (BA.2.12.1), SARS-CoV-2 Omicron (BA.2.75.2), SARS-CoV-2 (BA.2.3.20), SARS-CoV-2 (BA.2.75), SARS-CoV-2 Omicron (BA.4), SARS-CoV-2 Omicron (BA.4.6 / BF.7), SARS-CoV-2 Omicron (BA.5), SARS-CoV-2 Omicron (BQ.1.1), SARS-CoV-2 Omicron (XBB) | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
SARS-CoV/SARS-CoV-2 Spike Glycoprotein RBD | D006 | Chimeric | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 Omicron (BA.1.1), SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron (BA.2.12.1), SARS-CoV-2 Omicron (BA.2.75.2), SARS-CoV-2 (BA.2.3.20), SARS-CoV-2 (BA.2.75), SARS-CoV-2 Omicron (BA.4), SARS-CoV-2 Omicron (BA.4.6 / BF.7), SARS-CoV-2 Omicron (BA.5), SARS-CoV-2 Omicron (BQ.1.1), SARS-CoV-2 Omicron (XBB) | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
MUC5B | polyclonal | Rabbit | human | immunogen affinity purified | 100 µg | n/a |
BOSTER BIO |
More Info |
SARS-CoV-2 Spike Glycoprotein Neutralizing | 001 | Rabbit | SARS-CoV-2, SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 (BA.2.75), SARS-CoV-2 (BA.2.3.20); | unconjugated | 100 µg | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
SARS-CoV-2 Spike Glycoprotein Neutralizing | 57 | Mouse | SARS-CoV-2, SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 Omicron (BA.1.1); | unconjugated | 100 µg | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
SARS-CoV-2 Spike Glycoprotein S1 Subunit | 007 | Rabbit | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Delta (B.1.617.2); | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
SARS-CoV-2 Spike Glycoprotein S1 Subunit | 007 | Rabbit | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Delta (B.1.617.2); | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
ATP6V1C2 | OTI5C4 | Mouse | human, mouse, rat | biotin conjugate | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
ATP6V1C2 | OTI6D5 | Mouse | human, mouse, rat | biotin conjugate | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 Spike Protein | OTI5A7 | Mouse | SARS-CoV-2 | biotin conjugate | 100 µl | n/a |
ORIGENE TECHNOLOGIES |
More Info |
SARS-CoV-2 Spike Glycoprotein S1 Subunit Neutralizing | 43 | Mouse | SARS-CoV-2, SARS-CoV-2 Delta (B.1.617.2); | unconjugated | 100 µg | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
Influenza A H14N5 (A/mallard/Astrakhan/263/1982) Hemagglutinin Protein (HA1 Subunit) | monoclonal | Mouse | n/a | Protein A purified | 100µL | n/a |
SINO BIOLOGICAL, INC. |
More Info |
Pan-Nav1 Sodium Channel | N419/40 | Mouse | human, mouse, and rat | FL490 conjugate | 200 µL | n/a |
NEUROMAB |
More Info |
Pan-Nav1 Sodium Channel | N419/78 | Mouse | human, mouse, and rat | FL490 conjugate | 200 µL | n/a |
NEUROMAB |
More Info |
Pan-Nav1 Sodium Channel | N419/40 | Mouse | human, mouse, and rat | FL550 conjugate | 200 µL | n/a |
NEUROMAB |
More Info |
Pan-Nav1 Sodium Channel | N419/78 | Mouse | human, mouse, and rat | FL550 conjugate | 200 µL | n/a |
NEUROMAB |
More Info |
Pan-Nav1 Sodium Channel | N419/40 | Mouse | human, mouse, and rat | FL594 conjugate | 200 µL | n/a |
NEUROMAB |
More Info |
Pan-Nav1 Sodium Channel | N419/78 | Mouse | human, mouse, and rat | FL594 conjugate | 200 µL | n/a |
NEUROMAB |
More Info |
Pan-Nav1 Sodium Channel | N419/40 | Mouse | human, mouse, and rat | FL650 conjugate | 200 µL | n/a |
NEUROMAB |
More Info |
Pan-Nav1 Sodium Channel | N419/78 | Mouse | human, mouse, and rat | FL650 conjugate | 200 µL | n/a |
NEUROMAB |
More Info |
Pan-Nav1 Sodium Channel | N419/40 | Mouse | human, mouse, and rat | Protein A purified | 100 µL | n/a |
NEUROMAB |
More Info |
Pan-Nav1 Sodium Channel | N419/78 | Mouse | human, mouse, and rat | Protein A purified | 100 µL | n/a |
NEUROMAB |
More Info |
Cynomolgus B2M / beta-2 microglobulin | polyclonal | Rabbit | cynomolgus | Protein A purified | 100µL | n/a |
SINO BIOLOGICAL, INC. |
More Info |
Rat IL12B / IL-12B | polyclonal | Rabbit | rat | Protein A purified | 100µL | n/a |
SINO BIOLOGICAL, INC. |
More Info |
Hepatocyte Nuclear Factor 1 Beta (HNF1B) | polyclonal | Rabbit | human, mouse, rat | antigen affinity purified | 50 µl, 100 µl, | n/a |
ABBEXA LTD |
More Info |
ATP6V1F | OTI5F10 | Mouse | human, dog, rat, monkey, mouse | unconjugated | 100 µg | n/a |
ORIGENE TECHNOLOGIES |
More Info |
CACNA1S | polyclonal | Rabbit | human, mouse, rat | Alexa Fluor 350 conjugate | 100 µL | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |
CACNA1S | polyclonal | Rabbit | human, mouse, rat | Alexa Fluor 488 conjugate | 100 µL | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |
CACNA1S | polyclonal | Rabbit | human, mouse, rat | Alexa Fluor 555 conjugate | 100 µL | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |
CACNA1S | polyclonal | Rabbit | human, mouse, rat | Alexa Fluor 594 conjugate | 100 µL | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |
CACNA1S | polyclonal | Rabbit | human, mouse, rat | Alexa Fluor 647 conjugate | 100 µL | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |